Unikalo has acquired the Renaulac production site from Hempel
Hempel has sold its Renaulac production site to Unikalo.
Founded in 1936, Unikalo has become the first French independent player in the fields of building and decorative paints for the professional market.
Renaulac, a subsidiary of Hempel, produces paints for professional and DIY customers.
Hempel produces and sells coatings for the decorative, protective, marine, container and yacht markets. It was established in Denmark in 1915, and today it employs people across the globe. It is headquartered in Kongens Lyngby, near Copenhagen, Denmark.
Oaklins’ team in France assisted Unikalo in this transaction.
Talk to the deal team
Related deals
MEDIK Hospital Design Group has been acquired by STERIS
The private shareholders of MEDIK Hospital Design Group have sold their shares to STERIS plc. Together, MEDIK and STERIS will expand their offerings for hospitals and ambulatory surgery centers worldwide. MEDIK’s solutions ideally complement STERIS’ existing portfolio, enabling the combined group to strengthen its position as a leading provider of turnkey room solutions in surgical and IPT environments. The MEDIK management team will actively support the next phase of growth.
Learn moreBrand Group has acquired The Natoon Group
The Natoon Group has been acquired by Brand Group. This acquisition represents a significant strategic move that will help establish new, robust and stable growth channels. The transaction is intended to expand Brand Group’s revenues through service companies with recurring and predictable income streams supported by long-term contracts. As part of the agreement, Natoon’s senior management will continue to lead the company’s growth.
Learn moreSmile Invest has secured debt financing for the acquisition of RB+ Groep
Smile Invest has successfully acquired a majority stake in RB+ Groep, a specialist in comprehensive fire prevention solutions operating under the brands Van der Aa, Firejob and Preficon Europe, with a strong focus on constructional fire prevention. This transaction supports RB+’s growth ambitions and enables the company to expand into adjacent and international markets.
Learn more